DK333884A - Faste farmaceutiske formuleringer til langsom nulte-ordens frigivelse via kontrolleret overfladeerosion - Google Patents

Faste farmaceutiske formuleringer til langsom nulte-ordens frigivelse via kontrolleret overfladeerosion Download PDF

Info

Publication number
DK333884A
DK333884A DK333884A DK333884A DK333884A DK 333884 A DK333884 A DK 333884A DK 333884 A DK333884 A DK 333884A DK 333884 A DK333884 A DK 333884A DK 333884 A DK333884 A DK 333884A
Authority
DK
Denmark
Prior art keywords
pharmaceutically acceptable
compound
oral compositions
compositions
range
Prior art date
Application number
DK333884A
Other languages
English (en)
Other versions
DK162697C (da
DK162697B (da
DK333884D0 (da
Inventor
David R Powell
Vithal K Patel
Original Assignee
Rowell Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowell Lab Inc filed Critical Rowell Lab Inc
Publication of DK333884D0 publication Critical patent/DK333884D0/da
Publication of DK333884A publication Critical patent/DK333884A/da
Publication of DK162697B publication Critical patent/DK162697B/da
Application granted granted Critical
Publication of DK162697C publication Critical patent/DK162697C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Sliding Valves (AREA)
  • Electroplating Methods And Accessories (AREA)
DK333884A 1983-07-07 1984-07-06 Tabletter til langsom, nulte-ordens frigivelse via styret overfladeerosion DK162697C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51160583 1983-07-07
US06/511,605 US4539198A (en) 1983-07-07 1983-07-07 Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range

Publications (4)

Publication Number Publication Date
DK333884D0 DK333884D0 (da) 1984-07-06
DK333884A true DK333884A (da) 1985-01-08
DK162697B DK162697B (da) 1991-12-02
DK162697C DK162697C (da) 1992-04-21

Family

ID=24035636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK333884A DK162697C (da) 1983-07-07 1984-07-06 Tabletter til langsom, nulte-ordens frigivelse via styret overfladeerosion

Country Status (14)

Country Link
US (1) US4539198A (da)
EP (1) EP0131485B1 (da)
AT (1) ATE55900T1 (da)
AU (1) AU561633B2 (da)
CA (1) CA1224417A (da)
DE (1) DE3483072D1 (da)
DK (1) DK162697C (da)
ES (1) ES8600053A1 (da)
FI (1) FI842528A (da)
IL (1) IL72089A (da)
IT (1) IT1180193B (da)
NO (1) NO170753C (da)
NZ (1) NZ208393A (da)
ZA (1) ZA845208B (da)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500432A (da) * 1980-03-20 1982-03-11
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
US4832956A (en) * 1985-09-25 1989-05-23 Gerhard Gergely Disintegrating tablet and process for its preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
US6482516B1 (en) * 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
BR0013719A (pt) 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Dosagem oral de liberaçâo controlada, apropriada para administração oral
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
TWI249519B (en) 2000-08-29 2006-02-21 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
BR0207297A (pt) * 2001-02-15 2005-04-19 King Pharmaceuticals Inc Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030190359A1 (en) * 2001-10-29 2003-10-09 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
JP4062357B2 (ja) 2004-07-02 2008-03-19 明治乳業株式会社 固形乳，及びその製造方法
EP1773767B1 (en) 2004-07-07 2016-03-09 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
BRPI0514827A (pt) * 2004-09-01 2008-06-24 Procter & Gamble composições compreendendo ácido 5-amino-2hidróxi- benzóico e açúcar redutor
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP1924246B1 (en) 2005-09-15 2015-10-21 Genzyme Corporation Sachet formulation for amine polymers
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20110165236A1 (en) * 2006-09-22 2011-07-07 Biokey, Inc. Controlled release hydrogel formulation
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
EP3574914B1 (en) 2007-11-13 2021-12-29 ViroPharma Biologics LLC Corticosteroid compositions
EP2217215A1 (en) * 2007-12-14 2010-08-18 Genzyme Corporation Coated pharmaceutical compositions
EP2329823A4 (en) * 2008-09-03 2013-04-03 Takeda Pharmaceutical METHOD FOR IMPROVING CAPACITY OF PREPARATION TO BE ABSORBED AND PREPARATION WHICH CAPACITY TO BE ABSORBED IS IMPROVED
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
BR112012027794A2 (pt) 2010-04-30 2016-08-02 Takeda Pharmaceutical tablete entérico
JP5787881B2 (ja) 2010-04-30 2015-09-30 武田薬品工業株式会社 腸溶性錠剤
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
EP2425826A1 (en) 2010-09-01 2012-03-07 Disphar International B.V. Mesalazine tablet having improved dissolution
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
ITUA20162293A1 (it) 2016-04-05 2017-10-05 Sofar Spa Processo per formulazioni solide di mesalazina
EP3662898A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS57500432A (da) * 1980-03-20 1982-03-11

Also Published As

Publication number Publication date
CA1224417A (en) 1987-07-21
NO842766L (no) 1985-01-08
EP0131485B1 (en) 1990-08-29
DK162697C (da) 1992-04-21
AU2889884A (en) 1985-01-10
IT1180193B (it) 1987-09-23
ATE55900T1 (de) 1990-09-15
IL72089A (en) 1987-09-16
IT8421720A1 (it) 1986-01-02
AU561633B2 (en) 1987-05-14
ES534096A0 (es) 1985-10-01
IT8421720A0 (it) 1984-07-02
US4539198A (en) 1985-09-03
FI842528A (fi) 1985-01-08
IL72089A0 (en) 1984-10-31
EP0131485A2 (en) 1985-01-16
ZA845208B (en) 1985-03-27
EP0131485A3 (en) 1986-08-06
DK162697B (da) 1991-12-02
DE3483072D1 (de) 1990-10-04
NO170753B (no) 1992-08-24
NO170753C (no) 1992-12-02
ES8600053A1 (es) 1985-10-01
NZ208393A (en) 1987-03-31
FI842528A0 (fi) 1984-06-21
DK333884D0 (da) 1984-07-06

Similar Documents

Publication Publication Date Title
DK333884A (da) Faste farmaceutiske formuleringer til langsom nulte-ordens frigivelse via kontrolleret overfladeerosion
NO981027L (no) Bioadhesiv fast doseringsform
IL111647A (en) Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation
NO980669D0 (no) Orale raskt-opplöselige blandinger for dopaminagonister
RS49606B (sr) Farmaceutski preparat derivata n- piperidino-3- pirazolkarboksamida, njegovih soli i njihovih solvata za oralnu administraciju
GB9901819D0 (en) Pharmaceutical compositions
FI945081A (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
BG105436A (en) Pharmaceutical compositions comprising entacapone or nitecapone as well as a cross-linked cellulpse derivative
RS4204A (en) Dosage regimen and pharmaceutical composition for emergency contraception
FI921809A0 (fi) Foerfarande foer framstaellning av en tablett- eller dragekomposition, som innehaoller en foer vaerme, ljus och fuktighetkaenslig aktiv ingrediens med monoklinisk kristallstruktur.
DE69317418T2 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN
FR2444463A1 (fr) Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
KR910019625A (ko) 뼈의 무기질 소실을 억제하는 방법
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
MX9500324A (es) Compuestos farmaceuticos y el uso de los mismos en el tratamiento de enfermedades neurologicas y sus etiologias sintomaticas relacionadas.

Legal Events

Date Code Title Description
PBP Patent lapsed